These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Update on the association between alpha-synuclein and tau with mitochondrial dysfunction: Implications for Parkinson's disease. Feng ST; Wang ZZ; Yuan YH; Sun HM; Chen NH; Zhang Y Eur J Neurosci; 2021 May; 53(9):2946-2959. PubMed ID: 32031280 [TBL] [Abstract][Full Text] [Related]
7. The rescue of microtubule-dependent traffic recovers mitochondrial function in Parkinson's disease. Esteves AR; Gozes I; Cardoso SM Biochim Biophys Acta; 2014 Jan; 1842(1):7-21. PubMed ID: 24120997 [TBL] [Abstract][Full Text] [Related]
8. Mitochondrial damage by α-synuclein causes cell death in human dopaminergic neurons. Ganjam GK; Bolte K; Matschke LA; Neitemeier S; Dolga AM; Höllerhage M; Höglinger GU; Adamczyk A; Decher N; Oertel WH; Culmsee C Cell Death Dis; 2019 Nov; 10(11):865. PubMed ID: 31727879 [TBL] [Abstract][Full Text] [Related]
9. α-Synuclein pathology in Parkinson disease activates homeostatic NRF2 anti-oxidant response. Delaidelli A; Richner M; Jiang L; van der Laan A; Bergholdt Jul Christiansen I; Ferreira N; Nyengaard JR; Vægter CB; Jensen PH; Mackenzie IR; Sorensen PH; Jan A Acta Neuropathol Commun; 2021 Jun; 9(1):105. PubMed ID: 34092244 [TBL] [Abstract][Full Text] [Related]
10. Oxidative and nitrative alpha-synuclein modifications and proteostatic stress: implications for disease mechanisms and interventions in synucleinopathies. Schildknecht S; Gerding HR; Karreman C; Drescher M; Lashuel HA; Outeiro TF; Di Monte DA; Leist M J Neurochem; 2013 May; 125(4):491-511. PubMed ID: 23452040 [TBL] [Abstract][Full Text] [Related]
11. Regionally-specific microglial activation in young mice over-expressing human wildtype alpha-synuclein. Watson MB; Richter F; Lee SK; Gabby L; Wu J; Masliah E; Effros RB; Chesselet MF Exp Neurol; 2012 Oct; 237(2):318-34. PubMed ID: 22750327 [TBL] [Abstract][Full Text] [Related]
12. Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson's Disease. Zella MAS; Metzdorf J; Ostendorf F; Maass F; Muhlack S; Gold R; Haghikia A; Tönges L Cells; 2019 Jan; 8(2):. PubMed ID: 30708997 [TBL] [Abstract][Full Text] [Related]
13. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse. Perfeito R; Cunha-Oliveira T; Rego AC Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292 [TBL] [Abstract][Full Text] [Related]
14. High expression of α-synuclein in damaged mitochondria with PLA2G6 dysfunction. Sumi-Akamaru H; Beck G; Shinzawa K; Kato S; Riku Y; Yoshida M; Fujimura H; Tsujimoto Y; Sakoda S; Mochizuki H Acta Neuropathol Commun; 2016 Mar; 4():27. PubMed ID: 27030050 [TBL] [Abstract][Full Text] [Related]
15. Neuroinflammation in Parkinson's Disease and its Treatment Opportunities. Çınar E; Tel BC; Şahin G Balkan Med J; 2022 Sep; 39(5):318-333. PubMed ID: 36036436 [TBL] [Abstract][Full Text] [Related]
16. A Summary of Phenotypes Observed in the In Vivo Rodent Alpha-Synuclein Preformed Fibril Model. Polinski NK J Parkinsons Dis; 2021; 11(4):1555-1567. PubMed ID: 34486988 [TBL] [Abstract][Full Text] [Related]
17. DJ-1 interactions with α-synuclein attenuate aggregation and cellular toxicity in models of Parkinson's disease. Zondler L; Miller-Fleming L; Repici M; Gonçalves S; Tenreiro S; Rosado-Ramos R; Betzer C; Straatman KR; Jensen PH; Giorgini F; Outeiro TF Cell Death Dis; 2014 Jul; 5(7):e1350. PubMed ID: 25058424 [TBL] [Abstract][Full Text] [Related]
18. The subcellular arrangement of alpha-synuclein proteoforms in the Parkinson's disease brain as revealed by multicolor STED microscopy. Moors TE; Maat CA; Niedieker D; Mona D; Petersen D; Timmermans-Huisman E; Kole J; El-Mashtoly SF; Spycher L; Zago W; Barbour R; Mundigl O; Kaluza K; Huber S; Hug MN; Kremer T; Ritter M; Dziadek S; Geurts JJG; Gerwert K; Britschgi M; van de Berg WDJ Acta Neuropathol; 2021 Sep; 142(3):423-448. PubMed ID: 34115198 [TBL] [Abstract][Full Text] [Related]
19. Mitochondrial pyruvate carrier regulates autophagy, inflammation, and neurodegeneration in experimental models of Parkinson's disease. Ghosh A; Tyson T; George S; Hildebrandt EN; Steiner JA; Madaj Z; Schulz E; Machiela E; McDonald WG; Escobar Galvis ML; Kordower JH; Van Raamsdonk JM; Colca JR; Brundin P Sci Transl Med; 2016 Dec; 8(368):368ra174. PubMed ID: 27928028 [TBL] [Abstract][Full Text] [Related]
20. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease. Büeler H Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]